DE578765T1 - Verabreichung von röntgenkontrastmitteln durch rezeptorvermittelte endocytose. - Google Patents
Verabreichung von röntgenkontrastmitteln durch rezeptorvermittelte endocytose.Info
- Publication number
- DE578765T1 DE578765T1 DE0578765T DE92910570T DE578765T1 DE 578765 T1 DE578765 T1 DE 578765T1 DE 0578765 T DE0578765 T DE 0578765T DE 92910570 T DE92910570 T DE 92910570T DE 578765 T1 DE578765 T1 DE 578765T1
- Authority
- DE
- Germany
- Prior art keywords
- receptor
- administration
- mediated endocytosis
- contrasting agents
- ray contrasting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000010837 receptor-mediated endocytosis Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/18—Catalysts containing secondary or tertiary amines or salts thereof
- C08G18/1808—Catalysts containing secondary or tertiary amines or salts thereof having alkylene polyamine groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/18—Catalysts containing secondary or tertiary amines or salts thereof
- C08G18/1816—Catalysts containing secondary or tertiary amines or salts thereof having carbocyclic groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/18—Catalysts containing secondary or tertiary amines or salts thereof
- C08G18/1825—Catalysts containing secondary or tertiary amines or salts thereof having hydroxy or primary amino groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/18—Catalysts containing secondary or tertiary amines or salts thereof
- C08G18/20—Heterocyclic amines; Salts thereof
- C08G18/2009—Heterocyclic amines; Salts thereof containing one heterocyclic ring
- C08G18/2036—Heterocyclic amines; Salts thereof containing one heterocyclic ring having at least three nitrogen atoms in the ring
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/22—Catalysts containing metal compounds
- C08G18/24—Catalysts containing metal compounds of tin
- C08G18/244—Catalysts containing metal compounds of tin tin salts of carboxylic acids
- C08G18/246—Catalysts containing metal compounds of tin tin salts of carboxylic acids containing also tin-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/22—Catalysts containing metal compounds
- C08G18/26—Catalysts containing metal compounds of lead
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
- C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
- C08J9/143—Halogen containing compounds
- C08J9/144—Halogen containing compounds containing carbon, halogen and hydrogen only
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2101/00—Manufacture of cellular products
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
- C08J2375/04—Polyurethanes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/679,526 US5141739A (en) | 1986-07-03 | 1991-04-02 | Delivery of x-ray contrast agents using receptor mediated endocytosis |
PCT/US1992/002255 WO1992017216A1 (en) | 1991-04-02 | 1992-03-18 | Delivery of x-ray contrast agents using receptor mediated endocytosis |
Publications (1)
Publication Number | Publication Date |
---|---|
DE578765T1 true DE578765T1 (de) | 1994-05-26 |
Family
ID=24727269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE0578765T Pending DE578765T1 (de) | 1991-04-02 | 1992-03-18 | Verabreichung von röntgenkontrastmitteln durch rezeptorvermittelte endocytose. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5141739A (de) |
EP (1) | EP0578765A1 (de) |
JP (1) | JPH06506230A (de) |
CA (1) | CA2105068A1 (de) |
DE (1) | DE578765T1 (de) |
ES (1) | ES2061423T1 (de) |
GR (1) | GR940300022T1 (de) |
WO (1) | WO1992017216A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5490991A (en) * | 1986-07-03 | 1996-02-13 | Advanced Magnetics, Inc. | Directed delivery of radioprotectants using a receptor specific carrier |
GB8916782D0 (en) * | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
US5236694A (en) * | 1990-02-21 | 1993-08-17 | The Board Of Regents, The University Of Texas System | 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents |
AU642066B2 (en) * | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
DE4117782C2 (de) * | 1991-05-28 | 1997-07-17 | Diagnostikforschung Inst | Nanokristalline magnetische Eisenoxid-Partikel, Verfahren zu ihrer Herstellung sowie diagnostische und/oder therapeutische Mittel |
JP2894879B2 (ja) * | 1991-10-04 | 1999-05-24 | 日本メジフィジックス株式会社 | 診断用造影剤 |
US5342605A (en) * | 1992-05-01 | 1994-08-30 | Sterling Winthrop Inc. | Polymeric X-ray compositions containing iodinated polymeric beads |
US5871710A (en) * | 1992-09-04 | 1999-02-16 | The General Hospital Corporation | Graft co-polymer adducts of platinum (II) compounds |
DE69332952T2 (de) * | 1992-09-04 | 2004-02-19 | The General Hospital Corp., Boston | Diagnostische und therapeutische Einheiten enthaltende biokompatible Polymere |
US5340564A (en) * | 1992-12-10 | 1994-08-23 | Sterling Winthrop Inc. | Formulations comprising olin 10-G to prevent particle aggregation and increase stability |
US5336923A (en) * | 1992-12-31 | 1994-08-09 | Honeywell, Inc. | Varactor diode having a stepped capacitance-voltage profile |
US5342926A (en) * | 1993-06-08 | 1994-08-30 | The Regents Of The University Of California | Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport |
US5605672A (en) * | 1993-06-09 | 1997-02-25 | The General Hospital Corporation | Blood pool imaging composition and method of its use |
US6007845A (en) * | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
US20030119724A1 (en) * | 1995-11-22 | 2003-06-26 | Ts`O Paul O.P. | Ligands to enhance cellular uptake of biomolecules |
GB9705521D0 (en) | 1997-03-18 | 1997-05-07 | Univ Sheffield | The use of mononuclear phagocytes in the vivo imaging of hypoxic/ischaemic tissue |
DE19731591C2 (de) * | 1997-07-17 | 1999-09-16 | Schering Ag | Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie |
US6245316B1 (en) | 1997-10-08 | 2001-06-12 | David Platt | Enhancement of delivery of radioimaging and radioprotective agents |
US6093382A (en) * | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
US6723746B2 (en) | 1998-09-08 | 2004-04-20 | Veritas Pharmaceuticals, Inc. | Functional radiographic imaging methods and agents |
US6751290B2 (en) | 1998-09-08 | 2004-06-15 | Veritas Pharmaceuticals, Inc. | Radiographic assessment of tissue after exposure to a compound |
US6226352B1 (en) | 1998-09-08 | 2001-05-01 | Veritas Pharmaceuticals, Inc. | System and method for radiographic imaging of tissue |
US6426145B1 (en) | 1999-05-20 | 2002-07-30 | Scimed Life Systems, Inc. | Radiopaque compositions for visualization of medical devices |
FR2802817B1 (fr) * | 1999-12-23 | 2002-10-11 | Centre Nat Rech Scient | Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete |
US7169618B2 (en) * | 2000-06-28 | 2007-01-30 | Skold Technology | Magnetic particles and methods of producing coated magnetic particles |
JP2004536027A (ja) | 2000-12-01 | 2004-12-02 | ジョーンズ・ホプキンス・ユニーバーシティー | グリコシル化/ガラクトシル化ペプチドの接合体、二官能性リンカー、およびヌクレオチドのモノマー/ポリマー、および関連する組成物および使用方法 |
WO2002087629A1 (en) * | 2001-04-26 | 2002-11-07 | Analogic Corporation | Ct scanner for imaging a preselected portion of a patient |
WO2002100444A1 (en) * | 2001-06-08 | 2002-12-19 | Biosphere Medical Inc. | Colloidal metal labelled microparticles, their production and use |
US20050255175A1 (en) * | 2004-05-17 | 2005-11-17 | Burgess W P | Method for protecting nephron against injury caused by disruption of a chemical environment in the kidneys |
US20050255176A1 (en) * | 2004-05-17 | 2005-11-17 | Burgess W P | Method for attenuating free radical formation resulting from bodily insult |
US7019035B2 (en) * | 2004-05-17 | 2006-03-28 | Md Scientific Llc | Method for attenuating free radical formation resulting from bodily insult |
US7625586B2 (en) * | 2004-10-28 | 2009-12-01 | Md Scientific, Llc | Method for mitigating injury to a kidney resulting from an ischemic event |
KR100695744B1 (ko) | 2005-05-03 | 2007-03-19 | 한국원자력연구소 | 디티피에이(dtpa) 유도체 및 이들을 이용한 금속 착화물, 이들을 포함하는 방사선원 및 조영제 |
CN1966088B (zh) * | 2006-11-16 | 2010-09-29 | 中国科学院长春应用化学研究所 | 阿拉伯半乳聚糖为载体的磁共振成像造影剂 |
CN102159253A (zh) * | 2008-03-24 | 2011-08-17 | 得克萨斯大学体系董事会 | 心肌病的显像引导的治疗:组合物、制备和用途 |
CA2772023A1 (en) | 2009-08-18 | 2011-02-24 | Ben Gurion University Of The Negev Research And Development Authority | System and method for analyzing imaging data |
US9827265B1 (en) | 2012-04-06 | 2017-11-28 | Md Scientific, Llc | Method for attenuating free radical formation resulting from a bodily insult |
JP6420817B2 (ja) * | 2013-03-15 | 2018-11-07 | バイオコンパティブルズ ユーケー リミテッド | 結像可能な塞栓性微小球 |
EP4342978A2 (de) | 2016-09-01 | 2024-03-27 | Chimera Bioengineering Inc. | Goldoptimierte car-t-zellen |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR6024559D0 (pt) * | 1959-12-08 | 1973-05-31 | Nyegaard & Co As | Processo para preparacao de novos derivados de acido 3 5-diamino-2 4 6-triiodo benzoico ou semi sais nao toxicos bem como de agentes ou meios de contraste para raios x baseados nos mesmos |
IT1053508B (it) * | 1970-07-06 | 1981-10-10 | Searle & Co | Procedimento per prepare composizioni marcate adatte a mettere in evidenza alterazioni della mucosa gastrointestinale prodotto ottenuto e relativo metodo di impiego |
US4069306A (en) * | 1974-03-14 | 1978-01-17 | Pharmacia Aktiebolag | X-ray contrast preparation containing a hydrophilic polymer containing amino groups |
US4038379A (en) * | 1976-03-24 | 1977-07-26 | Nikolai Petrovich Elinov | Composition for roentgenoscopy of the gastrointestinal tract containing a polysaccharide stabilizer |
US4243653A (en) * | 1979-04-27 | 1981-01-06 | The Regents Of The University Of California | Non-ionic polyiodo sugar substituted anilines |
US4431626A (en) * | 1981-05-27 | 1984-02-14 | The Regents Of The University Of California | Tc-99m Labeled carrier for imaging |
WO1983001738A1 (en) * | 1981-11-12 | 1983-05-26 | SCHRÖDER, Ulf | Intravascularly administrable, magnetically responsive nanosphere or manoparticle, a process for the production thereof, and the use thereof |
US4396598A (en) * | 1982-01-11 | 1983-08-02 | Mallinckrodt, Inc. | Triiodoisophthalamide X-ray contrast agent |
FR2550449B1 (fr) * | 1983-08-12 | 1986-01-31 | Commissariat Energie Atomique | Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire |
CA1224003A (en) * | 1984-04-24 | 1987-07-14 | Robert S. Molday | Colloidal sized metal-polysaccharide particles |
US4542225A (en) * | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
SE465907B (sv) * | 1984-11-01 | 1991-11-18 | Nyegaard & Co As | Diagnosticeringsmedel innehaallande en paramagnetisk metall |
US4675173A (en) * | 1985-05-08 | 1987-06-23 | Molecular Biosystems, Inc. | Method of magnetic resonance imaging of the liver and spleen |
US4770183A (en) * | 1986-07-03 | 1988-09-13 | Advanced Magnetics Incorporated | Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents |
US4827945A (en) * | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
US4822594A (en) * | 1987-01-27 | 1989-04-18 | Gibby Wendell A | Contrast enhancing agents for magnetic resonance images |
US4859449A (en) * | 1987-09-14 | 1989-08-22 | Center For Molecular Medicine And Immunology | Modified antibodies for enhanced hepatocyte clearance |
EP0670167A1 (de) * | 1988-08-04 | 1995-09-06 | Advanced Magnetics Incorporated | Rezeptorinduzierte endocytoseartige diagnostische Mittel |
WO1990001900A1 (en) * | 1988-08-24 | 1990-03-08 | The University Of Connecticut | Carrier system and method for enhancement of magnetic resonance imaging |
AU628403B2 (en) * | 1988-09-29 | 1992-09-17 | Access Pharmaceuticals, Inc. | Methods and compositions for magnetic resonance imaging |
US5066789A (en) * | 1988-09-30 | 1991-11-19 | Neorx Corporation | Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages |
GB8919929D0 (en) * | 1989-09-04 | 1989-10-18 | Nycomed As | Compositions |
-
1991
- 1991-04-02 US US07/679,526 patent/US5141739A/en not_active Expired - Fee Related
-
1992
- 1992-03-18 ES ES92910570T patent/ES2061423T1/es active Pending
- 1992-03-18 EP EP92910570A patent/EP0578765A1/de not_active Ceased
- 1992-03-18 WO PCT/US1992/002255 patent/WO1992017216A1/en not_active Application Discontinuation
- 1992-03-18 CA CA002105068A patent/CA2105068A1/en not_active Abandoned
- 1992-03-18 JP JP4509688A patent/JPH06506230A/ja active Pending
- 1992-03-18 DE DE0578765T patent/DE578765T1/de active Pending
-
1994
- 1994-04-29 GR GR940300022T patent/GR940300022T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR940300022T1 (en) | 1994-04-29 |
EP0578765A1 (de) | 1994-01-19 |
US5141739A (en) | 1992-08-25 |
ES2061423T1 (es) | 1994-12-16 |
JPH06506230A (ja) | 1994-07-14 |
WO1992017216A1 (en) | 1992-10-15 |
CA2105068A1 (en) | 1992-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE578765T1 (de) | Verabreichung von röntgenkontrastmitteln durch rezeptorvermittelte endocytose. | |
DE69111667T2 (de) | Röntgenstrahlenkollimationsvorrichtung. | |
MX9102473A (es) | Agentes farmaceuticos. | |
DE69206349T2 (de) | Durch Andrücken verschliessbarer C-förmig gefalteter Rückantwort-Umschlagsatz. | |
EP0602700A3 (de) | Nanopartikeln enthaltende Röntgenkontrastmittel mit hochmolekularen Tensiden. | |
ITBO910024A1 (it) | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. | |
ITRM920361A1 (it) | Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. | |
DE59202990D1 (de) | Röntgenröhre. | |
NO905125L (no) | Administrerings-innretning. | |
DE69203471T2 (de) | Brausendes Bademittel. | |
ZA926020B (en) | Pharmaceutical combination formulation. | |
ATE123930T1 (de) | Darreichungsform für mikrobläschen- echokontrastmittel. | |
DE69107824D1 (de) | Statische Mischvorrichtung. | |
NO913733L (no) | Vaskemiddelblanding. | |
DE59203328D1 (de) | Feldstärkenmessgerät. | |
DE69112372D1 (de) | Planetenmischer. | |
DZ1559A1 (fr) | Compositions pharmaceutiques. | |
FR2687910B1 (fr) | Presentoir d'instrumentation dentaire. | |
DE59202485D1 (de) | Rührwerksmühle. | |
MX9200748A (es) | Formulaciones de esteroides. formulaciones de esteroides. | |
FI923607A0 (fi) | Foerbaettringar i pulpmaskiner foer att dispergera sellulosapulp. | |
DE69202924T2 (de) | Ablenkeinheit. | |
MX9200532A (es) | Agente farmaceuticos. | |
FR2695297B1 (fr) | Composition d'agent désinfectant. | |
FI923371A (fi) | En farmaceutisk formulation. |